Psych Vivas · Old age psychiatry — psychosis
Late-onset psychosis — structured clinical viva
Fellowship viva covering Howard consensus, partition delusions, organic exclusion, DLB trap, low-dose antipsychotic, Schneider mortality framing, and cognitive surveillance.
On this page & tools
Target exams
Opening move
State you will structure: risk and capacity → definitions → formulation → differentials → work-up → treatment (non-drug then drug) → dementia caution → follow-up. Do not launch into a drug name before safety and organic exclusion.[1][3]
Expected discussion points
1. Nosology
- LOS onset after 40; VLOSLP after 60 (Howard 2000).
- Not separate DSM codes; map to spectrum/medical categories.[1]
2. Phenomenology and formulation
- Partition delusions, persecutory content, relatively preserved affect historically in late paraphrenia teaching.
- Hearing loss and isolation as maintainers; collateral essential.[2]
3. Differentials
- Delirium, Alzheimer/vascular psychosis, DLB (fluctuation, visual hallucinations, RBD, parkinsonism, neuroleptic sensitivity), affective psychosis, substances, Charles Bonnet.[3][5]
- Do not diagnose irreversible dementia from one distressed cognitive screen.
4. Work-up
- Labs, ECG, sensory tests, neuroimaging for first late-onset psychosis; extended tests for red flags.[3][7]
5. Management
- Non-drug first always documented.
- Example: risperidone 0.25–0.5 mg PO with slow titration; monitor EPS, metabolic, falls, QTc.
- Response often at low–moderate atypical doses in VLOSLP series.[6]
- If dementia pathway: Schneider mortality signal; time-limited targeted use.[4]
6. Risk, legal, follow-up
- Neighbour harm, self-neglect, fire; least-restrictive legal framework (jurisdiction-specific).
- Cognitive surveillance given elevated later dementia risk in VLOSLP cohorts; watch for emerging DLB features.[5]
Examiner traps
Treating as uncomplicated young-adult FEP without imaging plan; high-dose or typical antipsychotic in possible DLB; calling it "just Alzheimer's" without formulation; ignoring hearing aids and isolation; no review date or risk–benefit documentation when dementia possible.[3][4][5]
Model synthesis (30–40 seconds)
"This is a first psychotic presentation after 60 consistent with VLOSLP construct after organic exclusion — partition delusions, sensory impairment, and social isolation feature. I will manage risk, complete labs/ECG/imaging, correct hearing and supports, start a low-dose atypical with monitoring, explicitly reconsider dementia/DLB over time, and avoid long-term high-dose antipsychotics without benefit."[1][4][6]
References
- [1]Howard R, Rabins PV, Seeman MV, Jeste DV Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus Am J Psychiatry, 2000.PMID 10671383
- [2]Howard R, Almeida O, Levy R Phenomenology, demography and diagnosis in late paraphrenia Psychol Med, 1994.PMID 8084935
- [3]Kim K, Jeon HJ, Myung W, et al. Clinical Approaches to Late-Onset Psychosis J Pers Med, 2022.PMID 35330384
- [4]Schneider LS, Dagerman KS, Insel P Risk of death with atypical antipsychotic drug treatment for dementia JAMA, 2005.PMID 16234500
- [5]Kanemoto H, Satake Y, Suehiro T, et al. Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies Alzheimers Res Ther, 2022.PMID 36138485
- [6]Scott J, Greenwald BS, Kramer E, Shuwall M Atypical (second generation) antipsychotic treatment response in very late-onset schizophrenia-like psychosis Int Psychogeriatr, 2011.PMID 21118614
- [7]Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med, 2009.PMID 19144938